BioCentury Grand Rounds conference highlights importance of big data
This year’s BioCentury Grand Rounds brought together researchers, biotech leaders, investors, and Nobel laureates in Seattle to explore how big data can accelerate medical breakthroughs.
Hosted at the Hyatt Regency and the Allen Institute, the conference focused on the role of research, patient and financial data in advancing drug development and strengthening collaboration between academia and industry. Organizers emphasized reducing translational bottlenecks by connecting scientific discoveries with the expertise and investment needed to bring new therapies to patients.
The conference reinforced the Seattle region’s leadership in data-driven life sciences and highlighted the importance of cross-sector collaboration for future biomedical innovation.